The Effect of Energy Drinks Consumption on Acute Physiological and Psychological Responses of Israeli Arab Adolescents
EDE
1 other identifier
interventional
150
1 country
1
Brief Summary
Quasi-experiment and Cross-sectional study, six-arm design protocol will be carried out. The study will be conducted under the Declaration of Helsinki. The current study will assess the effects of EDs consumption on the physiological and psychological responses of Israeli Arab adolescents. These effects will also be examined in association with the adolescent's plasma metabolite profiles. The study has five specific aims: (1) to assess the effects of ED consumption with or without a meal, on Israeli Arab adolescents glucose levels by using mixed meal tolerance test (MMTT) (2) to assess the effect of ED consumption with or without a meal on their blood pressure (3) to evaluate the association between ED consumption per day by the Israeli Arab adolescents and their nutritional status and habits (4) to examine for possible associations between Israeli Arab adolescents psychological status (i.e. mood and anxiety) and ED consumption per day (5) to examine for possible associations between ED and caffeine consumption and plasma metabolite profiles and, the subject's psychological status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2020
CompletedFirst Submitted
Initial submission to the registry
March 11, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedMarch 22, 2021
March 1, 2021
6 months
March 11, 2021
March 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Blood sugar change
Change in blood sugar levels (mg/dL) will be measured with the mixed meal tolerance test (MMTT) five times - one time at baseline (before consuming the meal) and four times during the intervention (15, 30, 60 and 120 minutes after consuming the meal).
First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal
Anxiety status
Anxiety status will be measured one time during the intervention - 60 minutes after consuming the meal, with the SCARED-R questionnaire (Muris et al., 1999) in Arabic. SCARED-R is a self-report questionnaire which measures anxiety status in the last 3 months. Contains 41 statements (such as "I am nervous") in Likert scale of 0 ("Not True or Hardly Ever True") to 2 ("Very True or Often True"). A total score of ≥ 25 may indicate the presence of an Anxiety Disorder.
During the intervention, 60 minutes after consuming the meal.
Mood change
Mood change will be measured two times - one time at baseline (before consuming the meal) and another time during the intervention - 60 minutes after consuming the meal. Mood will be measured with the UMACL questionnaire (Matthews et al., 1990) in Arabic. UMACL is a self-report questionnaire which measures the current mood of the subject. Contains 29 statements (such as "I am happy"), in Likert scale of 1 ("absolutely") to 4 ("not at all"). The higher the score, the better the current mood is.
First measurement at baseline, before consuming the meal, and another measurement during the intervention, 60 minutes after consuming the meal.
Insulin levels status
Insulin levels status will be measured based on blood samples that will be taken from subjects during the intervention, 30-45 minutes after consuming the meal. Analysis will take place after the data collection stage.
During the intervention, between 30-45 minutes after consuming the meal.
SCFA levels status
SCFA levels status will be measured based on blood samples that will be taken from subjects during the intervention, 30-45 minutes after consuming the meal. Analysis will take place after the data collection stage.
During the intervention, between 30-45 minutes after consuming the meal.
HR change
Changes in heart rate (BPM) will be measured five times - First at baseline (before consuming the meal) and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal.
First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal
Secondary Outcomes (4)
BP change
First measurement at baseline, before consuming the meal, and four times during the intervention - 15, 30, 60 and 120 minutes after consuming the meal
Life habits status
During intervention, 60 minutes after consuming the meal.
Energy drinks consumption status
During intervention, 60 minutes after consuming the meal.
Caffeine consumption frequency
During intervention, 60 minutes after consuming the meal.
Study Arms (6)
Drink A + SC
EXPERIMENTALIn t0 the group will receive 250 ml XL energy drink + 20 gr sucrose.
Drink B + SC
ACTIVE COMPARATORIn t0 the group will receive 250 ml Fanta soft drink + 20 gr sucrose.
Drink C + SC
ACTIVE COMPARATORIn t0 the group will receive 250 ml soda water + 47 gr sucrose.
Drink A + CC
EXPERIMENTALIn t0 the group will receive 250 ml XL energy drink + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.
Drink B + CC
ACTIVE COMPARATORIn t0 the group will receive 250 ml Fanta soft drink + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.
Drink C + CC
ACTIVE COMPARATORIn t0 the group will receive 250 ml soda water + 27gr sucrose + 20gr complex carbohydrates from one slice of bread (30g) and one spoon of hummus.
Interventions
Consumption of energy drink that contains 80mg caffeine and 27g carbohydrates per 250ml together with simple carbohydrates.
Consumption of soft drink, non-caffeine drink that contains 27g carbohydrates per 250ml together with simple carbohydrates.
Consumption of soda water, non-caffeine and non-carbohydrate drink together with simple carbohydrates.
Consumption of energy drink that contains 80mg caffeine and 27g carbohydrates per 250ml together with complex carbohydrates.
Consumption of soft drink, non-caffeine drink that contains 27g carbohydrates per 250ml together with complex carbohydrates.
Consumption of soda water, non-caffeine and non-carbohydrate drink together with complex carbohydrates.
Eligibility Criteria
You may qualify if:
- Healthy
- Israeli Arab adolescents
- aged 14.5-17.5 years
You may not qualify if:
- diabetes
- hypoglycemic episodes
- coronary heart disease, cardiac arrhythmia, secondary hypertension, structural heart lesions
- hepatic or renal disorders
- autonomic neuropathy
- epilepsy
- obstructive sleep apnea
- migraines
- caffeine intolerance
- eating disorders or other mental disorders or those with prescribed psychiatric medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Vincent De Paul hospital
Nazareth, 16511, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lili Nimri, Dr.
Nutritional sciences Department Tel-Hai College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2021
First Posted
March 22, 2021
Study Start
October 2, 2020
Primary Completion
April 1, 2021
Study Completion
October 1, 2022
Last Updated
March 22, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share